Burhan Savas, Ph.D.
Affiliations: | 2001 | Queen's University, Canada, Kingston, Ontario, Canada |
Area:
Cell Biology, Pharmacology, OncologyGoogle:
"Burhan Savas"Parents
Sign in to add mentor| Hugh Pross | grad student | 2001 | Queen's University, Canada | |
| (Implications for the role of the multidrug transporter P -glycoprotein in targets and effectors of interleukin -2 -activated killer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tatli AM, Arslan D, Uysal M, et al. (2015) Retrospective analysis of third-line chemotherapy in advanced non-small cell lung cancer. Journal of Cancer Research and Therapeutics. 11: 805-9 |
| Dobbs K, Domínguez Conde C, Zhang SY, et al. (2015) Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections. The New England Journal of Medicine. 372: 2409-22 |
| Yorulmaz G, Erdogan G, Pestereli HE, et al. (2007) Epithelioid leiomyosarcoma with rhabdoid features. Wiener Klinische Wochenschrift. 119: 557-60 |
| Savas B, Kerr PE, Pross HF. (2006) Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma. Cancer Cell International. 6: 24 |
| Yildiz M, Celik-Ozenci C, Akan S, et al. (2006) Zoledronic acid is synergic with vinblastine to induce apoptosis in a multidrug resistance protein-1 dependent way: an in vitro study. Cell Biology International. 30: 278-82 |
| Akan I, Akan S, Akca H, et al. (2005) Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine sulfoximine. Cancer Cell International. 5: 22 |
| Bozcuk H, Gumus A, Ozbilim G, et al. (2005) Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 11: HY11-20 |
| Akan I, Akan S, Akca H, et al. (2004) N-acetylcysteine enhances multidrug resistance-associated protein 1 mediated doxorubicin resistance. European Journal of Clinical Investigation. 34: 683-9 |
| Savas B, Kerr PE, Ustun H, et al. (1998) Lymphokine-activated killer cell susceptibility and multidrug resistance in small cell lung carcinoma. Anticancer Research. 18: 4355-61 |
| Savas B, Cole SP, Tsuruo T, et al. (1996) P-glycoprotein-mediated multidrug resistance and lymphokine-activated killer cell susceptibility in ovarian carcinoma. Journal of Clinical Immunology. 16: 348-57 |